OpenURL Connection Search

Select item for more details and to access through your institution.

Osimertinib for patients with EGFR T790M mutation-positive non–small-cell lung cancer and a poor performance status.
Published in:
Japanese Journal of Clinical Oncology, 2019, v. 49, n. 7, p. 671, doi. 10.1093/jjco/hyz041
By:
- Nakashima, Kazuhisa;
- Kimura, Madoka;
- Akamatsu, Hiroaki;
- Daga, Haruko;
- Imai, Hisao;
- Taira, Tetsuhiko;
- Ko, Ryo;
- Hisamatsu, Yasushi;
- Nishino, Kazumi;
- Sugimoto, Takeya;
- Miyashita, Yosuke;
- Takahashi, Toshiaki;
- al, et
Publication type:
Article
A Case Report of Epithelioid Inflammatory Myofibroblastic Sarcoma with RANBP2-ALK Fusion Gene Treated with the ALK Inhibitor, Crizotinib.
Published in:
Japanese Journal of Clinical Oncology, 2014, v. 44, n. 9, p. 868, doi. 10.1093/jjco/hyu069
By:
- Kimbara, Shiro;
- Takeda, Koji;
- Fukushima, Hiroko;
- Inoue, Toru;
- Okada, Hideaki;
- Shibata, Yumi;
- Katsushima, Utae;
- Tsuya, Asuka;
- Tokunaga, Shinya;
- Daga, Haruko;
- Okuno, Takahiro;
- Inoue, Takeshi
Publication type:
Article
Phase I study of weekly nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer.
Published in:
Investigational New Drugs, 2022, v. 40, n. 1, p. 106, doi. 10.1007/s10637-021-01155-w
By:
- Omori, Shota;
- Harada, Hideyuki;
- Mori, Keita;
- Hisamatsu, Yasushi;
- Tsuboguchi, Yuko;
- Yoshioka, Hiroshige;
- Morinaga, Ryotaro;
- Daga, Haruko;
- Kurata, Takayasu;
- Takahashi, Toshiaki
Publication type:
Article
Phase 1b study of ramucirumab in combination with erlotinib or osimertinib for untreated EGFR-mutated non–small cell lung cancer patients with asymptomatic brain metastases.
Published in:
Investigational New Drugs, 2021, v. 39, n. 6, p. 1598, doi. 10.1007/s10637-021-01147-w
By:
- Kaneda, Hiroyasu;
- Sawa, Kenji;
- Daga, Haruko;
- Okada, Asuka;
- Nakatani, Yuki;
- Atagi, Shinji;
- Okishio, Kyoichi;
- Tani, Yoko;
- Matsumoto, Yoshiya;
- Ogawa, Koichi;
- Nakahama, Kenji;
- Izumi, Motohiro;
- Mitsuoka, Shigeki;
- Kawaguchi, Tomoya
Publication type:
Article
Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial.
Published in:
Investigational New Drugs, 2020, v. 38, n. 6, p. 1854, doi. 10.1007/s10637-020-00943-0
By:
- Nakashima, Kazuhisa;
- Ozawa, Yuichi;
- Daga, Haruko;
- Imai, Hisao;
- Tamiya, Motohiro;
- Tokito, Takaaki;
- Kawamura, Takahisa;
- Akamatsu, Hiroaki;
- Tsuboguchi, Yuko;
- Takahashi, Toshiaki;
- Yamamoto, Nobuyuki;
- Mori, Keita;
- Murakami, Haruyasu
Publication type:
Article
Correction to: First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1.
Published in:
2023
By:
- Nishio, Makoto;
- Ohe, Yuichiro;
- Ikeda, Satoshi;
- Yokoyama, Toshihide;
- Hayashi, Hidetoshi;
- Fukuhara, Tatsuro;
- Sato, Yuki;
- Tanaka, Hiroshi;
- Hotta, Katsuyuki;
- Sugawara, Shunichi;
- Daga, Haruko;
- Okamoto, Isamu;
- Kasahara, Kazuo;
- Naito, Tateaki;
- Li, Li;
- Gupta, Ravi G.;
- Bushong, Judith;
- Mizutani, Hideaki
Publication type:
Correction Notice
First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1.
Published in:
International Journal of Clinical Oncology, 2023, v. 28, n. 10, p. 1354, doi. 10.1007/s10147-023-02390-2
By:
- Nishio, Makoto;
- Ohe, Yuichiro;
- Ikeda, Satoshi;
- Yokoyama, Toshihide;
- Hayashi, Hidetoshi;
- Fukuhara, Tatsuro;
- Sato, Yuki;
- Tanaka, Hiroshi;
- Hotta, Katsuyuki;
- Sugawara, Shunichi;
- Daga, Haruko;
- Okamoto, Isamu;
- Kasahara, Kazuo;
- Naito, Tateaki;
- Li, Li;
- Gupta, Ravi G.;
- Bushong, Judith;
- Mizutani, Hideaki
Publication type:
Article
Overall survival analysis of patients enrolled in a randomized phase III trial comparing gefitinib and erlotinib for previously treated advanced lung adenocarcinoma (WJOG5108LFS).
Published in:
International Journal of Clinical Oncology, 2023, v. 28, n. 1, p. 79, doi. 10.1007/s10147-022-02266-x
By:
- Katakami, Nobuyuki;
- Yokoyama, Toshihide;
- Morita, Satoshi;
- Okamoto, Tatsuro;
- Urata, Yoshiko;
- Hattori, Yoshihiro;
- Iwamoto, Yasuo;
- Sato, Yuki;
- Ikeda, Norihiko;
- Takahashi, Toshiaki;
- Daga, Haruko;
- Oguri, Tetsuya;
- Fujisaka, Yasuhito;
- Nishino, Kazumi;
- Sugawara, Shunichi;
- Kozuki, Toshiyuki;
- Oki, Masahide;
- Yamamoto, Nobuyuki;
- Nakagawa, Kazuhiko
Publication type:
Article
The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV.
Published in:
International Journal of Clinical Oncology, 2019, v. 24, n. 7, p. 731, doi. 10.1007/s10147-019-01431-z
By:
- Akamatsu, Hiroaki;
- Ninomiya, Kiichiro;
- Kenmotsu, Hirotsugu;
- Morise, Masahiro;
- Daga, Haruko;
- Goto, Yasushi;
- Kozuki, Toshiyuki;
- Miura, Satoru;
- Sasaki, Takaaki;
- Tamiya, Akihiro;
- Teraoka, Shunsuke;
- Tsubata, Yukari;
- Yoshioka, Hiroshige;
- Hattori, Yoshihiro;
- Imamura, Chiyo K.;
- Katsuya, Yuki;
- Matsui, Reiko;
- Minegishi, Yuji;
- Mizugaki, Hidenori;
- Nosaki, Kaname
Publication type:
Article
Treatment Rationale and Design for APPLE (WJOG11218L): A Multicenter, Open-Label, Randomized Phase 3 Study of Atezolizumab and Platinum/Pemetrexed With or Without Bevacizumab for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.
Published in:
2020
By:
- Shiraishi, Yoshimasa;
- Kishimoto, Junji;
- Tanaka, Kentaro;
- Sugawara, Shunichi;
- Daga, Haruko;
- Hirano, Katsuya;
- Azuma, Koichi;
- Hataji, Osamu;
- Hayashi, Hidetoshi;
- Tachihara, Motoko;
- Mitsudomi, Tetsuya;
- Seto, Takashi;
- Nakagawa, Kazuhiko;
- Yamamoto, Nobuyuki;
- Okamoto, Isamu
Publication type:
journal article
Phase I/II Study of Osimertinib With Bevacizumab in EGFR-mutated, T790M-positive Patients With Progressed EGFR-TKIs: West Japan Oncology Group 8715L (WJOG8715L).
Published in:
2019
By:
- Akamatsu, Hiroaki;
- Teraoka, Shunsuke;
- Morita, Satoshi;
- Katakami, Nobuyuki;
- Tachihara, Motoko;
- Daga, Haruko;
- Yamamoto, Nobuyuki;
- Nakagawa, Kazuhiko
Publication type:
journal article
Prospective Study of Urinary and Serum Cross-Linked N-Telopeptide of Type I Collagen (NTx) for Diagnosis of Bone Metastasis in Patients With Lung Cancer.
Published in:
Clinical Lung Cancer, 2013, v. 14, n. 4, p. 364, doi. 10.1016/j.cllc.2012.11.006
By:
- Tamiya, Motohiro;
- Tokunaga, Shinya;
- Okada, Hideaki;
- Suzuki, Hidekazu;
- Kobayashi, Masashi;
- Sasada, Shinji;
- Okamoto, Norio;
- Morishita, Naoko;
- Matsuura, Yuka;
- Miyamoto, Natsuko;
- Hattori, Michiyo;
- Taira, Koichi;
- Daga, Haruko;
- Takeda, Koji;
- Hirashima, Tomonori
Publication type:
Article
Predicting osimertinib‐treatment outcomes through EGFR mutant‐fraction monitoring in the circulating tumor DNA of EGFR T790M‐positive patients with non‐small cell lung cancer (WJOG8815L).
Published in:
Molecular Oncology, 2021, v. 15, n. 1, p. 126, doi. 10.1002/1878-0261.12841
By:
- Sakai, Kazuko;
- Takahama, Takayuki;
- Shimokawa, Mototsugu;
- Azuma, Koichi;
- Takeda, Masayuki;
- Kato, Terufumi;
- Daga, Haruko;
- Okamoto, Isamu;
- Akamatsu, Hiroaki;
- Teraoka, Shunsuke;
- Ono, Akira;
- Ohira, Tatsuo;
- Yokoyama, Toshihide;
- Yamamoto, Nobuyuki;
- Nakagawa, Kazuhiko;
- Nishio, Kazuto
Publication type:
Article
Efficacy of Olanzapine in Addition to Standard Triplet Antiemetic Therapy for Cisplatin-Based Chemotherapy: A Secondary Analysis of the J-FORCE Randomized Clinical Trial.
Published in:
JAMA Network Open, 2023, v. 6, n. 5, p. e2310894, doi. 10.1001/jamanetworkopen.2023.10894
By:
- Abe, Masakazu;
- Yamaguchi, Takuhiro;
- Fujita, Yukiyoshi;
- Nishimura, Tomoyasu;
- Kitagawa, Koichi;
- Inui, Naoki;
- Hirano, Katsuya;
- Sakata, Yukio;
- Iihara, Hirotoshi;
- Shibuya, Yuichi;
- Suzuki, Kenichi;
- Shibata, Kazuhiko;
- Hori, Kensuke;
- Daga, Haruko;
- Nakayama, Toshiaki;
- Sakata, Yasuhiko;
- Takahashi, Takako Yanai;
- Zenda, Sadamoto;
- Hashimoto, Hironobu
Publication type:
Article
Diagnostic Accuracy of Noninvasive Genotyping of EGFR in Lung Cancer Patients by Deep Sequencing of Plasma Cell-Free DNA.
Published in:
Clinical Chemistry, 2015, v. 61, n. 9, p. 1191, doi. 10.1373/clinchem.2015.241414
By:
- Junji Uchida;
- Kikuya Kato;
- Yoji Kukita;
- Toru Kumagai;
- Kazumi Nishino;
- Haruko Daga;
- Izumi Nagatomo;
- Takako Inoue;
- Madoka Kimura;
- Shigeyuki Oba;
- Yuri Ito;
- Koji Takeda;
- Fumio Imamura
Publication type:
Article
The Safety and Tolerability of Intravenous ASA404 When Administered in Combination with Docetaxel (60 or 75 mg/m2) in Japanese Patients with Advanced or Recurrent Solid Tumors.
Published in:
Japanese Journal of Clinical Oncology, 2011, v. 41, n. 9, p. 1067, doi. 10.1093/jjco/hyr110
By:
- Daga, Haruko;
- Hida, Toyoaki;
- Ishikawa, Shizu;
- Shimizu, Junichi;
- Tokunaga, Shinya;
- Horio, Yoshitsugu;
- Kobayashi, Ken;
- Takeda, Koji
Publication type:
Article
Phase I study of nintedanib in combination with pemetrexed as second-line treatment of Japanese patients with advanced non-small cell lung cancer.
Published in:
2015
By:
- Daga, Haruko;
- Takeda, Koji;
- Okada, Hideaki;
- Miyazaki, Masaki;
- Ueda, Shinya;
- Kaneda, Hiroyasu;
- Okamoto, Isamu;
- Yoh, Kiyotaka;
- Goto, Koichi;
- Konishi, Koichi;
- Sarashina, Akiko;
- Tanaka, Tetsuya;
- Kaiser, Rolf;
- Nakagawa, Kazuhiko
Publication type:
journal article
Phase I and pharmacokinetic study of gefitinib and S-1 combination therapy for advanced adenocarcinoma of the lung.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 859, doi. 10.1007/s00280-013-2077-1
By:
- Kiyota, Hidemi;
- Okamoto, Isamu;
- Takeda, Masayuki;
- Daga, Haruko;
- Naito, Tateaki;
- Miyazaki, Masaki;
- Okada, Hideaki;
- Hayashi, Hidetoshi;
- Tanaka, Kaoru;
- Terashima, Masaaki;
- Azuma, Koichi;
- Murakami, Haruyasu;
- Takeda, Koji;
- Yamamoto, Nobuyuki;
- Nakagawa, Kazuhiko
Publication type:
Article
Forthcoming Phase II Study of Durvalumab (MEDI4736) Plus Chemotherapy for Small Cell Lung Cancer with Brain Metastases.
Published in:
Cancer Management & Research, 2022, v. 14, p. 3449, doi. 10.2147/CMAR.S391220
By:
- Shiraishi, Yoshimasa;
- Shimose, Takayuki;
- Tsuchiya-Kawano, Yuko;
- Ishii, Hidenobu;
- Daga, Haruko;
- Ito, Kentaro;
- Saruwatari, Koichi;
- Okamoto, Isamu
Publication type:
Article
Rationale and Design for a Multicenter, Phase II Study of Durvalumab Plus Concurrent Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer: The DOLPHIN Study (WJOG11619L).
Published in:
Cancer Management & Research, 2021, v. 13, p. 9167, doi. 10.2147/CMAR.S336262
By:
- Tachihara, Motoko;
- Tsujino, Kayoko;
- Ishihara, Takeaki;
- Hayashi, Hidetoshi;
- Sato, Yuki;
- Kurata, Takayasu;
- Sugawara, Shunichi;
- Okamoto, Isamu;
- Teraoka, Shunsuke;
- Azuma, Koichi;
- Daga, Haruko;
- Yamaguchi, Masafumi;
- Kodaira, Takeshi;
- Satouchi, Miyako;
- Shimokawa, Mototsugu;
- Yamamoto, Nobuyuki;
- Nakagawa, Kazuhiko
Publication type:
Article
Plasma screening for the T790M mutation of EGFR and phase 2 study of osimertinib efficacy in plasma T790M-positive non-small cell lung cancer: West Japan Oncology Group 8815L/LPS study.
Published in:
2020
By:
- Takahama, Takayuki;
- Azuma, Koichi;
- Shimokawa, Mototsugu;
- Takeda, Masayuki;
- Ishii, Hidenobu;
- Kato, Terufumi;
- Saito, Haruhiro;
- Daga, Haruko;
- Tsuboguchi, Yuko;
- Okamoto, Isamu;
- Otsubo, Kohei;
- Akamatsu, Hiroaki;
- Teraoka, Shunsuke;
- Takahashi, Toshiaki;
- Ono, Akira;
- Ohira, Tatsuo;
- Yokoyama, Toshihide;
- Sakai, Kazuko;
- Yamamoto, Nobuyuki;
- Nishio, Kazuto
Publication type:
journal article
Bevacizumab beyond disease progression after first-line treatment with bevacizumab plus chemotherapy in advanced nonsquamous non-small cell lung cancer (West Japan Oncology Group 5910L): An open-label, randomized, phase 2 trial.
Published in:
2016
By:
- Takeda, Masayuki;
- Yamanaka, Takeharu;
- Seto, Takashi;
- Hayashi, Hidetoshi;
- Azuma, Koichi;
- Okada, Morihito;
- Sugawara, Shunichi;
- Daga, Haruko;
- Hirashima, Tomonori;
- Yonesaka, Kimio;
- Urata, Yoshiko;
- Murakami, Haruyasu;
- Saito, Haruhiro;
- Kubo, Akihito;
- Sawa, Toshiyuki;
- Miyahara, Eiji;
- Nogami, Naoyuki;
- Nakagawa, Kazuhiko;
- Nakanishi, Yoichi;
- Okamoto, Isamu
Publication type:
journal article
A randomized phase 3 study of maintenance therapy with S-1 plus best supportive care versus best supportive care after induction therapy with carboplatin plus S-1 for advanced or relapsed squamous cell carcinoma of the lung (WJOG7512L).
Published in:
2020
By:
- Tanaka, Kaoru;
- Morita, Satoshi;
- Ando, Masahiko;
- Yokoyama, Takuma;
- Nakamura, Atsushi;
- Yoshioka, Hiroshige;
- Ishiguro, Takashi;
- Miura, Satoru;
- Toyozawa, Ryo;
- Oguri, Tetsuya;
- Daga, Haruko;
- Ko, Ryo;
- Bessho, Akihiro;
- Tachihara, Motoko;
- Iwamoto, Yasuo;
- Hirano, Katsuya;
- Nakanishi, Yoichi;
- Nakagawa, Kazuhiko;
- Yamamoto, Nobuyuki;
- Okamoto, Isamu
Publication type:
journal article
Plasma screening for the T790M mutation of EGFR and phase 2 study of osimertinib efficacy in plasma T790M–positive non–small cell lung cancer: West Japan Oncology Group 8815L/LPS study.
Published in:
Cancer (0008543X), 2020, v. 126, n. 9, p. 1940, doi. 10.1002/cncr.32749
By:
- Takahama, Takayuki;
- Azuma, Koichi;
- Shimokawa, Mototsugu;
- Takeda, Masayuki;
- Ishii, Hidenobu;
- Kato, Terufumi;
- Saito, Haruhiro;
- Daga, Haruko;
- Tsuboguchi, Yuko;
- Okamoto, Isamu;
- Otsubo, Kohei;
- Akamatsu, Hiroaki;
- Teraoka, Shunsuke;
- Takahashi, Toshiaki;
- Ono, Akira;
- Ohira, Tatsuo;
- Yokoyama, Toshihide;
- Sakai, Kazuko;
- Yamamoto, Nobuyuki;
- Nishio, Kazuto
Publication type:
Article
Predictive value of EGFR mutation in non–small‐cell lung cancer patients treated with platinum doublet postoperative chemotherapy.
Published in:
Cancer Science, 2022, v. 113, n. 1, p. 287, doi. 10.1111/cas.15171
By:
- Takahashi, Toshiaki;
- Sakai, Kazuko;
- Kenmotsu, Hirotsugu;
- Yoh, Kiyotaka;
- Daga, Haruko;
- Ohira, Tatsuo;
- Ueno, Tsuyoshi;
- Aoki, Tadashi;
- Hayashi, Hidetoshi;
- Yamazaki, Koji;
- Hosomi, Yukio;
- Chen‐Yoshikawa, Toyofumi F.;
- Okumura, Norihito;
- Takiguchi, Yuichi;
- Sekine, Akimasa;
- Haruki, Tomohiro;
- Yamamoto, Hiromasa;
- Sato, Yuki;
- Akamatsu, Hiroaki;
- Seto, Takashi
Publication type:
Article
Tumor mutation burden as a biomarker for lung cancer patients treated with pemetrexed and cisplatin (the JIPANG‐TR).
Published in:
Cancer Science, 2021, v. 112, n. 1, p. 388, doi. 10.1111/cas.14730
By:
- Sakai, Kazuko;
- Tsuboi, Masahiro;
- Kenmotsu, Hirotsugu;
- Yamanaka, Takeharu;
- Takahashi, Toshiaki;
- Goto, Koichi;
- Daga, Haruko;
- Ohira, Tatsuo;
- Ueno, Tsuyoshi;
- Aoki, Tadashi;
- Nakagawa, Kazuhiko;
- Yamazaki, Koji;
- Hosomi, Yukio;
- Kawaguchi, Koji;
- Okumura, Norihito;
- Takiguchi, Yuichi;
- Sekine, Akimasa;
- Haruki, Tomohiro;
- Yamamoto, Hiromasa;
- Sato, Yuki
Publication type:
Article
A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients with advanced non-squamous non-small cell lung cancer.
Published in:
Medical Oncology, 2016, v. 33, n. 1, p. 1, doi. 10.1007/s12032-015-0715-7
By:
- Tamiya, Motohiro;
- Tamiya, Akihiro;
- Kaneda, Hiroyasu;
- Nakagawa, Kazuhiko;
- Yoh, Kiyotaka;
- Goto, Koichi;
- Okamoto, Hiroaki;
- Shimokawa, Tsuneo;
- Abe, Tetsuya;
- Tanaka, Hiroshi;
- Daga, Haruko;
- Takeda, Koji;
- Hirashima, Tomonori;
- Atagi, Shinji
Publication type:
Article

Found: 27